Millions of people take glucosamine to protect their joints. Now, a study has uncovered a troubling sign: Among people who already had mild cognitive impairment, those who took glucosamine showed a greater progression toward dementia.
The glucosamina It is sold over the counter and is one of the best-known joint supplements, often combined with chondroitin or MSM. Precisely because of its widespread use, the new findings have caught the attention of researchers.
El estudio encontró una asociación between its use and a faster progression toward dementia in people who already had mild cognitive impairment. This does not prove that glucosamine is the cause: other factors could explain the difference, and further research is needed.
For now, the finding should be interpreted as a symptom that warrants further investigation, not a reason to stop treatment without consulting a healthcare professional.
CIENCIALA SOMBRA DEL AGUJERO NEGRO RESISTE UNA NUEVA PRUEBA
